Table 4.
Type of seizure and long-term outcome.
|
SZR FA +
(n = 15) |
SZR −
(n = 584) |
p | |
| Disability, n (%) | 9 (60) | 379 (64.9) | 0.7 |
| Mortality, n (%) | 8 (53.3) | 436 (74.7) | 0.06 |
|
SZR GTC +
(n = 15) |
SZR −
(n = 584) |
p | |
| Disability, n (%) | 13 (86.7) | 379 (64.9) | 0.08 |
| Mortality, n (%) | 14 (93.3) | 436 (74.7) | 0.08 |
|
SZR FBTC +
(n = 11) |
SZR −
(n = 584) |
p | |
| Disability, n (%) | 10 (90.9) | 379 (64.9) | 0.06 |
| Mortality, n (%) | 8 (72.7) | 436 (74.7) | 0.5 |
|
SZR FIA +
(n = 10) |
SZR −
(n = 584) |
p | |
| Disability, n (%) | 8 (80) | 379 (64.9) | 0.3 |
| Mortality, n (%) | 6 (60) | 436 (74.7) | 0.2 |
SZR FA+: patients with focal aware seizures; SZR GTC+: patients with generalized tonic-clonic seizures; SZR FBTC+: patients with focal to bilateral tonic-clonic seizures; SZR FIA+: patients with focal impaired awareness seizures; SZR −: patients without post-stroke seizures.